Evidence map›Paper›PMID 41814127›Full record

ArticleThe journal of physical chemistry. B2026

Pentameric Architecture of the SARS-CoV-2 Envelope Protein Revealed by SEC-MALS, Cryo-EM, and Molecular Dynamics.

Zi-Wen Weng, Danny Farhat, Jyh-Yeuan Lee, Shang-Te Danny Hsu

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zi-Wen WengInstitute of Biological Chemistry, Academia Sinica, 128 Academia Road, Sec. 2, Nankang, Taipei 11529, Taiwan.
Danny FarhatDepartment of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.
Jyh-Yeuan LeeDepartment of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.ORCID 0000-0003-1799-2416
Shang-Te Danny HsuInstitute of Biological Chemistry, Academia Sinica, 128 Academia Road, Sec. 2, Nankang, Taipei 11529, Taiwan.ORCID 0000-0002-7231-0185

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 envelope (E) protein is a small viroporin that drives viral assembly, budding, and host interactions, yet its structural organization has remained elusive. Earlier nuclear magnetic resonance spectroscopy studies hint at oligomerization without direct evidence, and the construct lacks the flexible C-terminal region. To bridge this gap, we synthesized the full-length E protein to investigate its oligomeric state. Using size-exclusion chromatography coupled with multiangle light scattering, we demonstrated that the E protein assembles as a stable pentamer in solution. We then reconstituted the E protein into membrane scaffold protein nanodiscs to mimic the lipid bilayer environment for structural analyses by negative-stain electron microscopy and cryo-electron microscopy, which revealed pentamer-like features. Molecular dynamics simulations of the E protein in a nanodisc and a membrane bilayer setting further corroborated the structural flexibility of the C-terminal domain. Collectively, these data present direct evidence that the SARS-CoV-2 E protein assembles as a pentamer in both solution and membrane-mimetic environments. Our results provide a structural foundation for future investigations into the E protein's roles in ion channel activity, membrane remodeling, and virus-host interactions.

Indexed as

Coronavirus Envelope ProteinsMolecular Dynamics SimulationSARS-CoV-2Chromatography, GelCryoelectron MicroscopyLipid BilayersProtein MultimerizationCoronavirus Envelope Proteinsenvelope protein, SARS-CoV-2Lipid Bilayers

Identifiers

PMID41814127
PMCPMC13158902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.